SMTL ID : 2wkm.1

X-ray Structure of PHA-00665752 bound to the kinase domain of c-Met

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.20 Å

Oligo State

monomer

Ligands

1 x PFY: (3Z)-5-[(2,6-DICHLOROBENZYL)SULFONYL]-3-[(3,5-DIMETHYL-4-{[(2S)-2-(PYRROLIDIN-1-YLMETHYL)PYRROLIDIN-1-YL]CARBONYL}-1H-PYRROL-2-YL)METHYLIDENE]-1,3-DIHYDRO-2H-INDOL-2-ONE(Non-covalent)

PFY.1: 17 residues within 4Å: Chain A: V.43, A.59, L.91, L.108, P.109, Y.110, M.111, K.112, H.113, G.114, R.159, N.160, M.162, A.172, D.173, A.177, Y.181 9 PLIP interactions: 9 interactions with chain A Hydrophobic interactions: A:L.91, A:L.108, A:Y.110, A:M.111 Hydrogen bonds: A:P.109, A:M.111 Water bridges: A:D.115 pi-Stacking: A:Y.181 Halogen bonds: A:N.160

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Cui, J.J. et al., Structure Based Drug Design of Crizotinib (Pf-02341066), a Potent and Selective Dual Inhibitor of Mesenchymal-Epithelial Transition Factor (C-met) Kinase and Anaplastic Lymphoma Kinase (Alk). J.Med.Chem (2011)

Release Date

2010-08-25

Peptides

HEPATOCYTE GROWTH FACTOR RECEPTOR: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

HEPATOCYTE GROWTH FACTOR RECEPTOR

Related Entries With Identical Sequence